Methods for treating cancer resistant to ErbB therapeutics

Details for Australian Patent Application No. 2008239594 (hide)

Owner Beth Israel Deaconess Medical Center Dana Farber Cancer Institute The General Hospital Corporation D/B/A

Inventors Janne, Pasi A.; Cantley, Lewis C.; Engelman, Jeffrey

Agent Shelston IP

Pub. Number AU-A-2008239594

PCT Pub. Number WO2008/127710

Priority 60/923,384 13.04.07 US

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/404 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/127710 Priority application(s): WO2008/127710

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239595-Interferons of Rhesus and Cynomolgus origin and uses thereof

2008239593-Apparatus and method of enhancing the quality of high-moisture materials and separating and concentrating organic and/or non-organic material contained therein